Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 7, 2005, Pages 915-919

  Yoo, Seong Ho ^a   Jung, Kyeong Cheon ^b   Kim, Joo Hyun ^b   Sung, Sook Whan ^b   Chung, Jin Haeng ^b   Shim, Young Soo ^b   Lee, Soong Deok ^b   Chung, Doo Hyun ^b  

^a Ministry of National Defense   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD44V6 ANTIGEN; CD56 ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; MUCIN 1; PROGESTERONE RECEPTOR; SYNAPTOPHYSIN; THOMSEN FRIEDENREICH ANTIGEN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; BETA GALACTOSYL(1 3) N ACETYLGALACTOSAMINE; BETA-GALACTOSYL(1-3)-N-ACETYLGALACTOSAMINE; GLYCOPROTEIN; HERMES ANTIGEN; MUC1 PROTEIN, HUMAN; MUCIN; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS LUNG; HISTIOCYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL TYPE 2; LUNG DEVELOPMENT; LUNG PARENCHYMA; POLYGONAL CELL; PROTEIN EXPRESSION; PULMONARY SCLEROSING HEMANGIOMA; RESPIRATORY EPITHELIUM; STEM CELL; SURFACE CELL; TISSUE SECTION; TUMOR CELL; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PRENATAL DEVELOPMENT;

ADULT; AGED; ANTIGENS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MIDDLE AGED; MUCINS; NUCLEAR PROTEINS; PULMONARY SCLEROSING HEMANGIOMA; TRANSCRIPTION FACTORS;

EID: 21344455491     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000;24:1531-1536.
2. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD, A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24:906-916.
3. Tanaka I, Inoue M, Matsui Y, et al. A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol. 1986;16: 77-86.
4. Yano M, Yamakawa Y, Kiriyama M, Hara M, Murase T. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg. 2002;73:981-983.
5. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E: in collaboration with Sobin LH and pathologists from 14 countries. Histological Typing of Lung and Pleural Tumors. 3rd ed. Berlin, Germany: Springer-Verlag, 1999. World Health Organization International Histological Classification of Tumors.
6. Niho S, Suzuki K, Yokose T, et al. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol. 1998;152: 1065-1069.
7. Alvarez-Fernandez E, Carretero-Albinana L, Menarguez-Palanca J. Sclerosing hemangioma of the lung: an immunohistochemical study of intermediate filaments and endothelial markers. Arch Pathol Lab Med. 1989;113:121-124.
8. Haas JE, Yunis EJ, Totten RS. Ultrastructure of 3 sclerosing hemangioma of the lung. Cancer. 1972;30:512-518.
9. Katzenstein AL, Gmelich JT, Carrington CB. Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol. 1980;4:343-356.
10. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer. 1956;9:53-75.
11. Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung: immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer. 1985;55:116-123.
12. Xu HM, Li WH, Hou N, et al. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study. Am J Surg Pathol. 1997;21:1013-1022.
13. Yousem SA, Wick MR, Singh C, et al. So-called sclerosing hemangiomas of lung: an immunohistochemical study supporting a respiratory epithelial origin. Am J Surg Pathol. 1988;12:582-590.
14. Chambers JA, Hollingsworth MA, Trezise AE, Harris A. Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci. 1994;107:413-424.
15. Jarrard JA, Linnoila RI, Lee H, Steinberg SM, Witschi H, Szabo E. MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res. 1998;58:5582-5589.
16. Toma V, Sata T, Vogt P, Komminoth P, Heitz PU, Roth J. Differentiation-related expression of the Thomsen-Friedenreich glycotope in developing human lung and in lung carcinoma: lack of association with malignancy. Cancer. 1999; 85:2151-2159.
17. Cao Y, Stosiek P, Springer GF, Karsten U. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol. 1996;106:197-207.
18. Hachiya T, Honda T, Kubo K, Sekiguchi M. Expression patterns of type II pneumocyte apical surface glycoconjugates in lung adenocarcinoma cells. Virchows Arch. 2000;434:63-69.
19. Honda T, Ishida K, Hayama M, Kubo K, Katsuyama T. Type II pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anat Rec. 2000;258:34-38.
20. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313.
21. Kasper M, Cunthert U, Dall P, et al. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am J Respir Cell Mol Biol. 1995;13:648-656.
22. Palacios JI, Escribano PM, Toledo J, Garzon A, Larru E, Palomera J. Sclerosing hemangioma of the lung: an ultrastructural study. Cancer. 1979;44:949-955.
23. Satoh Y, Tsuchiya E, Weng SY, et al. Pulmonary sclerosing hemangioma of the lung: a type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer. 1989;64:1310-1317.